Details for 2017849474
Up to date per 02.04.2026
Actions
Details for 2017849474
Granted/Registered
European Patent
24.07.2019 A
08.12.2021 B1
07.09.2016
US
201662384664 P
A61K 31/675 20060101AFI20200424BHEP
Owner
ATEA Pharmaceuticals, Inc.125 Summer Street Boston, MA 02110US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
SOMMADOSSI, Jean-Pierrec/o Atea Pharmaceuticals, Inc. 125 Summer Street Boston, MA 02110US
MOUSSA, Adelc/o Atea Pharmaceuticals, Inc. 125 Summer Street Boston, MA 02110US
Information about Fees